Literature DB >> 9568694

Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.

E D Kilpatrick1, R P Robertson.   

Abstract

Refractoriness of the pancreatic beta-cell to glucose stimulation plays a role in the secretory defect of NIDDM, but the mechanisms underlying this refractoriness are not clear. The purpose of this study was to determine whether the HIT-T15 pancreatic beta-cell line can be used as an investigative model for refractoriness of glucose-induced insulin secretion and, if so, whether the mechanism for this refractoriness involves alteration in stimulus-secretion coupling (desensitization) or results from exhaustion of insulin stores. In perifusion experiments, acute insulin responses (AIRs) in HIT-T15 cells progressively diminished during consecutive 5-min glucose (11.1 mmol/l) pulses (G) given every 20 min (G1=9.2+/-1.3, G2=4.1+/-1.0, G3=2.7+/-0.7, G4=2.5+/-1.1 microU/ml). To determine whether this refractoriness for glucose extended to the potentiating effects of glucose on nonglucose secretagogues, cells were challenged with arginine after desensitization with glucose. In HIT-T15 cells, the response to the arginine pulse (16.7+/-5.2 microU/ml) after three glucose pulses was significantly less (P < 0.01) than the response to a control arginine pulse (29.6+/-12.1 microU/ml) preceded by an infusion of buffer in the absence of glucose pulses. Variable rest periods after desensitization allowed recovery of the AIR in HIT-T15 cells; responses 30, 60, 90, and 120 min after the desensitization procedure increased in a stepwise fashion (3.8+/-2.7, 4.5+/-2.7, 7.8+/-5.2, and 9.7+/-5.3 microU/ml, respectively). To differentiate desensitization from exhaustion of insulin stores, studies were performed in the presence of epinephrine, a potent inhibitor of insulin secretion. In HIT-T15 cells, after three pulses of glucose during the epinephrine infusion, epinephrine was discontinued and the insulin response to a fourth pulse was assessed. The G4 AIR (1.9+/-0.6 microU/ml) was markedly less than a control G4 AIR (5.4+/-1.2 microU/ml) that followed an epinephrine infusion alone with no concurrent glucose pulses. Beta-cell refractoriness was also induced in the HIT-T15 cell using 45-min steady-state infusions of glucose. Cells were exposed to a 45-min infusion of either 3.7 or 11.1 mmol/l glucose, rested for 20 min in the absence of glucose, and then challenged with a 5-min, 11.1 mmol/l glucose pulse. In both cases, the AIR to the 5-min pulse (10.2+/-5.1 and 2.9+/-1.4 microU/ml after the 3.7 and 11.1 mmol/l infusion, respectively) was lower than the AIR to a control pulse (27.4+/-5.9 microU/ml) not preceded by glucose infusion. These studies demonstrated that the HIT-T15 cell line is an appropriate model for studying mechanisms of beta-cell refractoriness to glucose signaling. The short-term intensive glucose stimulation paradigms used in our studies induced an abnormality in insulin secretion that is consistent with desensitization but not beta-cell exhaustion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568694     DOI: 10.2337/diabetes.47.4.606

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species.

Authors:  N Produit-Zengaffinen; N Davis-Lameloise; H Perreten; D Bécard; A Gjinovci; P A Keller; C B Wollheim; P Herrera; P Muzzin; F Assimacopoulos-Jeannet
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

2.  Autocrine effect of Zn²⁺ on the glucose-stimulated insulin secretion.

Authors:  Kira G Slepchenko; Nigel A Daniels; Aili Guo; Yang V Li
Journal:  Endocrine       Date:  2015-03-15       Impact factor: 3.633

Review 3.  Molecular basis for the integration of inositol phosphate signaling pathways via human ITPK1.

Authors:  Stephen B Shears
Journal:  Adv Enzyme Regul       Date:  2009-01-03

Review 4.  Beta-cell deterioration during diabetes: what's in the gun?

Authors:  R Paul Robertson
Journal:  Trends Endocrinol Metab       Date:  2009-09-11       Impact factor: 12.015

5.  β-cell function preservation after 3.5 years of intensive diabetes therapy.

Authors:  Lindsay B Harrison; Beverley Adams-Huet; Philip Raskin; Ildiko Lingvay
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

6.  No need for the needle (at first).

Authors:  Mayer B Davidson
Journal:  Diabetes Care       Date:  2008-10       Impact factor: 17.152

7.  Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.

Authors:  Harn-Shen Chen; Tzu-En Wu; Tjin-Shing Jap; Li-Chuan Hsiao; Shen-Hung Lee; Hong-Da Lin
Journal:  Diabetes Care       Date:  2008-06-12       Impact factor: 17.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.